Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Highlights
– First patient dosed in phase 1/2 trial of TNG462, a next-generation PRMT5 inhibitor for…
ISP
InvestmentPitch Media Video Features FSD Pharma’s Definitive Agreement Granting Exclusive Rights for Launch of UNBUZZD, a Revolutionary Rapid Alcohol Detoxification Drink
VANCOUVER, British Columbia, Aug. 03, 2023 (GLOBE NEWSWIRE) — FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A),…
Editas Medicine and Azzur Group Expand Partnership to Accelerate Editas’ Manufacturing Capabilities for Advancing the EDIT-301 Program Through Approval to Commercialization
CAMBRIDGE, Mass., and DEVENS, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq:…
Editas Medicine and Azzur Group Expand Partnership to Accelerate Editas’ Manufacturing Capabilities for Advancing the EDIT-301 Program Through Approval to Commercialization
CAMBRIDGE, Mass., and DEVENS, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq:…
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2023 Earnings and Company Updates
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage…
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2023 Earnings and Company Updates
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage…
Editas Medicine Announces Second Quarter 2023 Results Conference Call and Corporate Update
CAMBRIDGE, Mass., July 26, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage…
Editas Medicine Announces Second Quarter 2023 Results Conference Call and Corporate Update
CAMBRIDGE, Mass., July 26, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage…
Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process
TORONTO, July 25, 2023 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX:AH, OTCQB:ALEAF) (“Aleafia” or the…
Editas Medicine Strengthens Executive Leadership Team with Appointment of Linda C. Burkly, Ph.D., as Chief Scientific Officer
Linda Burkly Editas Medicine today announced the appointment of Linda C. Burkly, Ph.D., as the…
Editas Medicine Strengthens Executive Leadership Team with Appointment of Linda C. Burkly, Ph.D., as Chief Scientific Officer
Linda Burkly Editas Medicine today announced the appointment of Linda C. Burkly, Ph.D., as the…
Energix Renewables, First Solar Enter into Framework Agreement
Modules to be delivered between 2026 and 2030 for projects in Israel, Poland, and US…
SparingVision sells ex vivo GIRK technology to Tenpoint Therapeutics
SparingVision sells ex vivo GIRK technology to Tenpoint Therapeutics SparingVision remains focused on in vivo…
SparingVision sells ex vivo GIRK technology to Tenpoint Therapeutics
SparingVision sells ex vivo GIRK technology to Tenpoint Therapeutics SparingVision remains focused on in vivo…
U.S. National Institutes of Health to Fund $4.2 Million Contract to Advance Development of Pluri’s PLX-R18 in Conjunction with U.S. DoD as a Medical Countermeasure for Hematopoietic Acute Radiation Syndrome
Nuclear Disaster and Radiation Exposure Nuclear Disaster and Radiation Exposure Pluri’s cell therapy is designed…
Acerus Update
TORONTO, July 10, 2023 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “Company”) announces that, in…
FDA Grants Traditional Approval for LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease
The first and only approved treatment shown to reduce the rate of disease progression and…
Thirteen New Biospecimen Suppliers Added to iSpecimen’s Proprietary Provider Network
Network’s Expansion Across the U.S. and Europe Aims to Advance Translational Genomics Research LEXINGTON, Mass.,…
Thirteen New Biospecimen Suppliers Added to iSpecimen’s Proprietary Provider Network
Network’s Expansion Across the U.S. and Europe Aims to Advance Translational Genomics Research LEXINGTON, Mass.,…
Arrcus Showcases Cutting-Edge Networking Solutions at JANOG52 in Japan
News Summary Arrcus routing and switching solutions to demonstrate cost-effective performance at Japan JANOG52 event…